Sarepta Therapeutics, Inc. SRPT Intangible Purchases
Intangible Purchases at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireIntangibleAssets.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s intangible purchases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s intangible purchases?
- Sarepta Therapeutics, Inc. (SRPT) reported intangible purchases of $1M in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s intangible purchases changed year-over-year?
- Sarepta Therapeutics, Inc.'s intangible purchases decreased by 55.3% year-over-year, from $2.24M to $1M.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s intangible purchases?
- Over 2 years (2021 to 2025), Sarepta Therapeutics, Inc.'s intangible purchases has grown at a 84.7% compound annual growth rate (CAGR), from $2.31M to $7.88M.
- What does intangible purchases mean?
- Cash spent acquiring intangible assets such as patents, licenses, and other intellectual property.